Earlier evidence showed that CD40 gene expression is significantly reduced in IBC compared with non-IBC samples, but we could not validate CD40 decreased expression at the protein level due to the scarcity of IBC samples [50]. This evidence concerns the gene CD40 and inflammatory breast carcinoma.